Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating activities    
Net loss $ (428,697,000) $ (378,274,000)
Adjustments to reconcile net loss to cash used for operating activities:    
Depreciation 200,262,000 187,748,000
Amortization of intangible and other assets 2,026,000 3,632,000
Amortization of debt issue costs 7,994,000 4,942,000
Non-cash accretion on convertible notes 0 1,739,000
Amortization of NCM screen advertising advances and other deferred revenues (24,253,000) (23,647,000)
Amortization of accumulated losses for amended swap agreements 3,371,000 5,338,000
Impairment of long-lived assets 7,480,000 41,214,000
Share based awards compensation expense 16,589,000 12,859,000
(Gain) loss on disposal of assets and other 7,883,000 (10,997,000)
Loss on extinguishment of debt 6,527,000
Non-cash rent expense (1,803,000) 1,649,000
Equity in loss of affiliates 22,061,000 27,711,000
Deferred income tax expenses (21,059,000) (29,941,000)
Distributions from equity investees 156,000 25,430,000
Changes in assets and liabilities and other 141,537,000 (54,782,000)
Net cash used for operating activities (42,203,000) (167,653,000)
Investing activities    
Additions to theatre properties and equipment (57,244,000) (67,618,000)
Proceeds from sale of theatre properties and equipment and other 2,192,000 212,000
Investment in joint ventures and other, net 0 (50,000)
Net cash used for investing activities (55,052,000) (67,456,000)
Financing activities    
Dividends paid to stockholders 0 (42,311,000)
Payroll taxes paid as a result of stock withholdings (16,000) (2,865,000)
Proceeds from issuance of convertible notes 0 460,000,000
Proceeds from issuance of senior notes 1,170,000,000 250,000,000
Proceeds from other borrowings 9,706,000 7,167,000
Redemption of senior notes (1,155,000,000)  
Repayments of long-term debt (7,220,000) (4,947,000)
Payment of debt issue costs (17,272,000) (24,981,000)
Fees paid related to debt refinancing (2,058,000)  
Purchase of convertible note hedges 0 (142,094,000)
Proceeds from warrants issued 0 89,424,000
Payments on finance leases [1] (11,045,000) (11,497,000)
Other 0 (392,000)
Net cash provided by (used for) financing activities (12,905,000) 577,504,000
Effect of exchange rate changes on cash and cash equivalents (2,165,000) (5,002,000)
Increase (decrease) in cash and cash equivalents (112,325,000) 337,393,000
Cash and cash equivalents:    
Beginning of period 655,338,000 488,313,000
End of period 543,013,000 825,706,000
NCM    
Adjustments to reconcile net loss to cash used for operating activities:    
Interest accrued on NCM screen advertising advances $ 17,723,000 $ 17,726,000
[1] As discussed above at Lease Deferrals and Abatements, the Company negotiated certain lease amendments to defer and/or abate contractual payments as a result of the COVID-19 pandemic and temporary closure of theatres. In accordance with FASB Staff guidance, the Company did not recalculate lease liabilities and right of use assets for amendments that did not result in a substantial increase in the rights of the lessor or the obligations of the lessee. Contractual payment amounts for the nine months ended September 30, 2021 above are prior to the impact of deferred or abated rent amounts.